July 02, 2010

Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?

Listen Later

13 minutes

A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.”

One of the study’s principal authors, Kausik K. Ray, talked with us from London. I think you’ll find that listening in is worth your time.

Interview-related links:

Physician’s First Watch coverage of the Archives‘s statin papers

Ray et al.‘s meta-analysis

News-related links:

Starting dialysis early doesn’t improve mortality

Digoxin’s dangers in dialysis

Rosiglitazone’s bad week

Tight glucose control in diabetes brings some benefits, but at the cost of “imprudent” risks

PSA testing for prostate cancer lowers mortality, but mostly in low-screening regions

The post Podcast 94: What does a new meta-analysis tell us about statins and primary prevention? first appeared on Clinical Conversations.

...more

View all episodes

View all episodes

Download on the App Store

Download on the App Store

Get it on Google Play

Clinical Conversations

By NEJM Group

4.5

5656 ratings

July 02, 2010

Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?

Listen Later

13 minutes

A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.”

One of the study’s principal authors, Kausik K. Ray, talked with us from London. I think you’ll find that listening in is worth your time.

Interview-related links:

Physician’s First Watch coverage of the Archives‘s statin papers

Ray et al.‘s meta-analysis

News-related links:

Starting dialysis early doesn’t improve mortality

Digoxin’s dangers in dialysis

Rosiglitazone’s bad week

Tight glucose control in diabetes brings some benefits, but at the cost of “imprudent” risks

PSA testing for prostate cancer lowers mortality, but mostly in low-screening regions

The post Podcast 94: What does a new meta-analysis tell us about statins and primary prevention? first appeared on Clinical Conversations.

...more